Drug Search Results
More Filters [+]

Resolvin e1

Alternative Names: resolvin e1, rx-10001, Resolvin-E1, RvE1, RvE1, resolvin E1
Latest Update: 2023-10-06
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Immunomodulator Immuno

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Resolvyx
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Resolvin e1

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

RX-10001-002

P1

Completed

Healthy Volunteers

2009-09-01

Recent News Events